Trials / Completed
CompletedNCT00151489
Safety and Efficacy Study of Pregabalin in Fibromyalgia
A Six-Month, Double-Blind, Placebo Controlled, Durability of Effect Study of Pregabalin for Pain Associated With Fibromyalgia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,020 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study of pregabalin and fibromyalgia is to see if 1. pregabalin reduces the pain of fibromyalgia and if this effect lasts for six months and 2. to see if different dosages work better (reduce pain and mild to no side effects) for different people.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin | |
| DRUG | placebo |
Timeline
- Start date
- 2005-04-01
- Completion
- 2006-06-01
- First posted
- 2005-09-09
- Last updated
- 2021-01-22
Locations
109 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00151489. Inclusion in this directory is not an endorsement.